James Jisu Han

James Jisu Han

Auto-generated profile, based on publicly available information

James Jisu Han

Department of Molecular Biophysics and Biochemistry, Yale University, CITY, STATE, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2021 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
YYYixuan Ye
Yixuan Ye
XCXi Chen
Xi Chen
JHJames Han
James Han
WJWei Jiang
Wei Jiang
PNPradeep Natarajan
Pradeep Natarajan
HZHongyu Zhao
Hongyu Zhao
Background - Both lifestyle and genetic factors confer risk for cardiovascular diseases, type 2 diabetes (T2D), and dyslipidemia. However, the interactions between these two groups of risk factors were not comprehensively understood due to previous poor estimation of genetic risk. Here we set out to develop enhanced polygenic risk scores (PRS), and systematically investigate multiplicative and additive interactions between PRS and lifestyle for coronary artery disease, atrial fibrillation, T2D, total cholesterol, triglyceride, and LDL-cholesterol. Methods - Our study included 276,096 unrelated white British participants from the UK Biobank. We investigated several PRS methods (P+T, LDpred, PRS-CS, and AnnoPred), and showed that AnnoPred achieved consistently improved prediction accuracy for all six diseases/traits. With enhanced PRS and combined lifestyle status categorized by smoking, body mass index, physical activity, and diet, we investigated both multiplicative and additive interactions between PRS and lifestyle using regression models. Results - We observed that healthy lifestyle reduced disease incidence by similar multiplicative magnitude across different PRS groups. The absolute risk reduction (ARR) from lifestyle adherence was however significantly greater in individuals with higher PRS. Specifically, for T2D, the ARR from lifestyle adherence was 12.4% (95% CI, 10.0%-14.9%) in the top 1% PRS versus 2.8% (95% CI, 2.3%-3.3%) in the bottom PRS decile, leading to a ratio of more than 4.4. We also observed a significant interaction effect between PRS and lifestyle on triglyceride level. Conclusions - By leveraging functional annotations, AnnoPred outperforms state-of-the-art methods on quantifying genetic risk through PRS. Our analyses based on enhanced PRS suggest that individuals with high genetic risk may derive similar relative but greater absolute benefit from lifestyle adherence.

1 November 2024 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
SPSang-Won Park
Sang-Won Park
JHJames Jisu Han
James Jisu Han
NHNam Hun Heo
Nam Hun Heo
ELEun Chae Lee
Eun Chae Lee
Dong-Hun LeeDong-Hun Lee
Dong-Hun Lee
JOJAE SANG OH
JAE SANG OH
Objective : Intracerebral hemorrhage (ICH) accompanies higher mortality rates than other type of stroke. This study aimed to investigate the association between hospital volume and mortality for cases of ICH.Methods : We used nationwide data from 2013 to 2018 to compare high-volume hospitals (≥32 admissions/year) and low-volume hospitals (<32 admissions/year). We tracked patients’ survival at 3-month, 1-year, 2-year, and 4-year endpoints. The survival of ICH patients was analyzed at 3-month, 1-year, 2-year, and 4-year endpoints using Kaplan-Meier survival analysis. Multivariable logistic regression analysis and Cox regression analysis were performed to determine predictive factors of poor outcomes at discharge and death.Results : Among 9086 ICH patients who admitted to hospital during 18-month period, 6756 (74.4%) and 2330 (25.6%) patients were admitted to high-volume and low-volume hospitals. The mortality of total ICH patients was 18.25%, 23.87%, 27.88%, and 35.74% at the 3-month, 1-year, 2-year, and 4-year, respectively. In multivariate logistic analysis, high-volume hospitals had lower poor functional outcome at discharge than low-volume hospitals (odds ratio, 0.80; 95% confidence interval, 0.72–0.91; p<0.001). In the Cox analysis, high-volume hospitals had significantly lower 3-month, 1-year, 2-year, and 4-year mortality than low-volume hospitals (p<0.05).Conclusion : The poor outcome at discharge, short- and long-term mortality in ICH patients differed according to hospital volume. High-volume hospitals showed lower rates of mortality for ICH patients, particularly those with severe clinical status.